Abiomed in the News Abiomed CEO Michael Minogue recently appeared on Mad Money with Jim Cramer to talk about how Abiomed's dedication to putting Patients First is what drives our success. Latest Press Releases Abiomed Announces Record Revenue of $261 Million, up 13% Year Over Year February 3, 2022 Read More Early Feasibility Study Demonstrates Successful Use of Abiomed’s preCARDIA Technology January 12, 2022 Read More Regulators Approve Impella 5.5® with SmartAssist® in Japan and Hong Kong; US FDA Grants Impella BTR® Conditional IDE Approval for First-in-Human Early Feasibility Study January 10, 2022 Read More Learn More about Abiomed
